Cargando…
Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms
BACKGROUND: Malignant neoplasia of the adrenal cortex is usually associated with very poor prognosis. When adrenocortical neoplasms are diagnosed in the early stages, distinction between carcinoma and adenoma can be very difficult to accomplish, since there is yet no reliable marker to predict tumor...
Autores principales: | Barbosa, Angela S, Giacaglia, Luciano R, Martin, Regina M, Mendonca, Berenice B, Lin, Chin J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC476742/ https://www.ncbi.nlm.nih.gov/pubmed/15239841 http://dx.doi.org/10.1186/1472-6823-4-3 |
Ejemplares similares
-
GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
por: Gara, Sudheer Kumar, et al.
Publicado: (2020) -
GATA4/6 regulate DHH transcription in rat adrenocortical autografts
por: Yoshida, Takashi, et al.
Publicado: (2020) -
Adrenocortical Neoplasms in Children: Treatment and Outcomes
por: Jain, Vishesh, et al.
Publicado: (2022) -
The Role of Immunohistochemical Markers for the Diagnosis and Prognosis of Adrenocortical Neoplasms
por: Angelousi, Anna, et al.
Publicado: (2021) -
GATA2 deficiency and related myeloid neoplasms
por: Wlodarski, Marcin W., et al.
Publicado: (2017)